Paul Sequeira



(440) 471-1195

Paul Sequeira came to Newry in 2015 from Thermalin Diabetes, a Cleveland biotech startup, where he was involved in new product development and supported efforts to secure venture capital funding. As a Newry consultant, Paul has worked on a range of efforts, including opportunity evaluation for a drug delivery technology, opportunity identification for market-leading micro-circuit materials, finding new applications for a venting product in life sciences, and market analysis and strategy development for an architectural glass tempering product.

In addition to his work on client engagements, Paul is part of an internal core team developing Newry’s data analytics capabilities and proprietary big data resources.